| 发明名称 | Treatment for basal cell carcinoma | ||
| 摘要 | The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered. | ||
| 申请公布号 | US8835394(B2) | 申请公布日期 | 2014.09.16 |
| 申请号 | US201113276068 | 申请日期 | 2011.10.18 |
| 申请人 | Medicis Pharmaceutical Corporation | 发明人 | Owens Mary L.;Fox Terrance L.;Ginkel Angela M. |
| 分类号 | A61K38/00;A61K31/70;A01N57/00 | 主分类号 | A61K38/00 |
| 代理机构 | Kilpatrick Townsend & Stockton LLP | 代理人 | Kilpatrick Townsend & Stockton LLP |
| 主权项 | 1. A method of treating basal cell carcinoma in a subject, the method consisting essentially of administering to the subject an amount of an Immune Response Modifier (IRM) compound effective for treating basal cell carcinoma, wherein administering the IRM compound comprises topically applying the IRM compound to a treatment area that includes a lesion, and wherein the IRM compound is administered in a treatment cycle that comprises five consecutive days in which the IRM compound is administered and at least two consecutive days in which the IRM compound is not. | ||
| 地址 | Bridgewater NJ US | ||